한글목차

세계의 원격의료 시장은 2024년에 1,182억 5,000만 달러로 평가되었고, 2033년까지는 6,999억 5,000만 달러에 이를 것으로 예측되며, 예측 기간 중 2025년부터 2033년까지 CAGR은 16.7%로 성장할 전망입니다.

원격의료는 디지털 기술을 이용하여 의료 서비스에 액세스하고 원격으로 관리하는 것입니다. 재택의 개인이든, 지역의 의료 종사자도 이용할 수 있습니다. 원격의료는 또한 의료 서비스 제공업체가 헬스케어 서비스를 강화하거나 지원하는 데 사용할 수 있으며, 예를 들어 원격 액세스 및 원격 관리를 위해 컴퓨터 및 모바일 기기를 사용할 수 있습니다.

시장 역학 :

촉진요인 및 억제요인

원격 환자 모니터링 요구 증가

세계의 원격의료 시장은 원격 환자 모니터링에 대한 수요가 증가함에 따라 성장하고 있습니다. 당뇨병, 심혈관 질환, 호흡기 질환 등의 만성 질환이 만연함에 따라 건강 관리 시스템은 지속적인 치료를 제공하는 효율적인 방법을 찾고 있습니다. 원격 환자 모니터링을 통해 헬스케어 제공업체는 환자의 생명 신호 및 건강 데이터를 실시간으로 추적할 수 있어 의료비 절감과 환자 결과 개선이 가능합니다. 고령화의 진전과 웨어러블 디바이스, 모바일 헬스 용도, IoT 기술의 진보로 원격 모니터링 솔루션 수요가 더욱 높아지고 있습니다.

예를 들어, 2024년 7월 TeleMedCare는 미국 최고급 의료 보험 제공업체와 만성 환자에 대한 원격 모니터링 프로그램을 시작하여 5개 주에서 50만 명 이상을 다뤘습니다. 플로리다에 본사를 둔 이 프로그램은 CHF, COPD, 당뇨병, 고혈압 등의 만성 심장 질환, 호흡기 질환, 대사 질환 환자 300명을 대상으로 합니다. 이 프로그램은 TeleMedCare의 20억 달러 규모의 세계 보건 전략 계획의 일환으로 기업의 요구 사항과 프로토콜에 대한 적응성에 중점을 둡니다. 초기 파일럿 단계에서는 만성 질환 환자 300명을 대상으로 합니다.

개발 도상 지역의 견고한 인프라 부족 및 제한된 디지털 리터러시

세계 원격의료 시장은 개발도상 지역에서의 불충분한 인프라와 한정된 디지털 리터러시에 의한 과제에 직면하고 있습니다. 열악한 인터넷 연결, 고도의 통신 시스템 및 스마트 장치에 대한 액세스는 원격의료의 효과를 방해합니다. 제한된 디지털 리터러시도 도입을 방해합니다. 높은 비용과 정부 지원은 시장 성장을 더욱 방해합니다. 인프라, 기술 및 교육에 대한 투자가 필요합니다.

목차

제1장 조사 방법 및 조사 범위

제2장 정의 및 개요

제3장 주요 요약

제4장 시장 역학

• 영향요인
  • 성장 촉진요인
    • 원격 환자 모니터링의 필요성 증가
  • 성장 억제요인
    • 개발 도상 지역에서 견고한 인프라 부족 및 디지털 리터러시의 한계
  • 기회
  • 영향 분석

제5장 산업 분석

• Porter's Five Forces 분석
• 공급망 분석
• 가격 분석
• 규제 분석

제6장 컴포넌트별

• 하드웨어
• 소프트웨어
• 서비스

제7장 배포 모드별

• 온프레미스
• 클라우드 기반

제8장 용도별

• 만성 질환 관리
• 정신 건강 및 행동 장애
• 방사선과
• 심장병학
• 신경학
• 피부과
• 기타

제9장 최종 사용자별

• 의료 제공자
• 환자
• 지불자
• 기타

제10장 지역별

• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 스페인
  • 이탈리아
  • 기타 유럽
• 남미
  • 브라질
  • 아르헨티나
  • 기타 남미
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타 아시아태평양
• 중동 및 아프리카

제11장 경쟁 구도

• 경쟁 시나리오
• 시황 및 점유율 분석
• M&A 분석

제12장 기업 프로파일

• Teladoc Health, Inc
  • 기업 개요
  • 제품 포트폴리오
    • 제품 설명
    • 제품의 주요 실적 평가 지표(KPI)
    • 과거 및 예측의 제품 판매
    • 제품 판매량
  • 재무 개요
    • 회사 수익
    • 지역별 수익분배
    • 수익 예측
  • 주요 발전
    • 합병 및 인수
    • 주요 제품 개발 활동
    • 규제 당국의 승인 등
  • SWOT 분석
• American Well Corporation(Amwell)
• MDLIVE Inc.
• Doctor On Demand, Inc
• Philips Healthcare
• Medtronic plc
• GE Healthcare
• Siemens Healthineers AG
• Epic Systems Corporation
• Doximity
• Babylon Health
  • 파이프라인 제품 설명
  • 제품의 주요 실적 평가 지표(KPI)
  • 주요 활동
  • 시장 진입의 타임라인
  • 제품 보급률
  • 매출 예측과 예측
• K Health
• Hims & Hers Health, Inc
• MyDoc
• 각 시장 진출 기업에 대해서도 유사한 데이터가 제공됩니다.

제13장 부록

영문목차

The Global Telehealth Market reached US$ 118.25 billion in 2024 and is expected to reach US$ 699.95 billion by 2033, growing at a CAGR of 16.7% during the forecast period 2025-2033.

Telehealth is the use of digital technologies to access and manage healthcare services remotely. It can be used by individuals from home or by healthcare professionals in rural areas. Telehealth can also be used by healthcare providers to enhance or support healthcare services, such as using computers and mobile devices for remote access or remote care.

Market Dynamics: Drivers & Restraints

Rising Need for Remote Patient Monitoring

The global telehealth market is growing due to the increasing demand for remote patient monitoring. As chronic diseases like diabetes, cardiovascular conditions, and respiratory disorders become more prevalent, healthcare systems are seeking efficient ways to provide continuous care. Remote patient monitoring allows healthcare providers to track patients' vital signs and health data in real-time, reducing healthcare costs and improving patient outcomes. The growing aging population and advancements in wearable devices, mobile health applications, and IoT technologies further increase the demand for remote monitoring solutions.

For instance, in July 2024, TeleMedCare launched a remote chronic patient monitoring program with a top health insurance provider in the U.S., covering over 500,000 people in five states. The program, based in Florida, aims to address 300 patients with chronic heart, respiratory, and metabolic conditions like CHF, COPD, diabetes, and hypertension. The program is part of TeleMedCare's two-billion-dollar global health strategy plan, focusing on adaptability to company requirements and protocols. The initial pilot phase is addressing 300 patients with chronic conditions.

Lack of Robust Infrastructure and Limited Digital Literacy in Developing Regions

The global telehealth market faces challenges due to inadequate infrastructure and limited digital literacy in developing regions. Poor internet connections, advanced telecommunications systems, and smart device access hinder telehealth effectiveness. Limited digital literacy also hinders adoption. High costs and government support further hinder market growth. Investments in infrastructure, technology, and education are needed.

Segment Analysis

The global telehealth market is segmented based on, Component, Delivery Mode, Application, End User and Region.

Product Type:

Hardware segment is expected to dominate the Telehealth market share

The hardware segment holds a major portion of the telehealth market share and is expected to continue to hold a significant portion of the telehealth market share during the forecast period.

Hardware is crucial in the global telehealth market, providing essential tools and devices for real-time data collection, analysis, and transmission between patients and healthcare providers. Advancements in hardware technology, such as portable diagnostic devices and IoT-enabled health monitoring gadgets, have improved the accuracy and accessibility of telehealth services. The integration of these devices with cloud platforms and mobile applications enhances the scalability of telehealth solutions, making them more efficient for patients and providers.

For instance, in November 2024, Thailand is introduced telehealth kiosks to modernize its healthcare system, allowing patients to measure vital signs like temperature, pulse, respiration, and blood pressure. The collected data is then transmitted to an online system for remote consultations with doctors. The 30-baht universal healthcare scheme allows patients to choose home delivery or pick up from participating pharmacies, aligning with the government's vision of expanding the service into a "30-baht anywhere" service, making quality healthcare more accessible and reducing hospital burden.

End User:-

Healthcare providers segment is the fastest-growing segment in Telehealth market share

The healthcare providers segment is the fastest-growing segment in the telehealth market share and is expected to hold the market share over the forecast period.

Healthcare providers are driving the global telehealth market by promoting virtual consultations, remote patient monitoring, and follow-up care. They build trust, educate patients about telehealth, and address privacy and usability concerns. Integrating telehealth into routine care reduces the burden on traditional facilities, especially in managing chronic diseases and emergency consultations. Active participation, supported by training programs and government incentives, is crucial in scaling telehealth adoption across different regions and demographics.

For instance, in June 2024, Apollo Telehealth and the Government of Manipur have launched a telemedicine-driven primary health center in Borobeka, Manipur, to improve healthcare access for communities affected by recent conflicts. The area, known for its isolation and challenging road conditions, faces significant obstacles to accessing timely medical care and emergency services. The nearest referral hospital is located 90 minutes away in Jiribam, causing prolonged treatment and health concerns.

Geographical Analysis

North America is expected to hold a significant position in the Telehealth market share

North America holds a substantial position in the telehealth market and is expected to hold most of the market share due to its, high adoption of digital health technologies, and focus on cost reduction. The region's high prevalence of chronic diseases like diabetes and cardiovascular disorders makes telehealth an ideal solution. Government policies, such as reimbursement for services and funding programs, encourage adoption. The widespread use of smartphones, high-speed internet, AI, and IoT also accelerates market growth.

For instance, in August 2024, Pfizer has launched PfizerForAll, a digital platform designed to simplify healthcare access and health management for Americans. The platform supports Billions affected by common illnesses like migraine, COVID-19, or flu, as well as those seeking adult vaccinations. It consolidates critical resources and services into a single destination, reducing the time and steps needed for important health actions like getting care, filling prescriptions, and finding potential savings on Pfizer medicines.

Europe is growing at the fastest pace in the Telehealth market

Europe holds the fastest pace in the telehealth market and is expected to hold most of the market share fueled by the need to improve healthcare access in rural areas and reduce the burden on overstretched systems. The aging population in countries like Germany, Italy, and the UK has increased the demand for remote patient monitoring and virtual consultations. The integration of digital technologies, government initiatives, and EHR adoption, along with advancements in telecommunication infrastructure, enhances the efficiency and accessibility of telehealth services.

For instance, Doctorsa, a global telehealth platform, has launched in the UK, connecting travellers with local doctors within five minutes. The platform, founded in Italy, has expanded internationally to 33 countries and has served over 100,000 users. Doctorsa connects tourists and UK residents seeking urgent care, especially those facing long waits for GP appointments or needing support outside surgery hours. The platform aims to meet the growing demand for accessible healthcare in the UK.

Competitive Landscape

The major global players in the telehealth market include Epic Systems Corporation, Oracle Corporation, Veradigm LLC, MEDITECH, McKesson Corporation, GE Healthcare, NXGN Management, LLC, Athenahealth, eClinicalWorks, Greenway Health and among others.

Key Developments

• In August 2024, VSee Health, Inc. has launched its Aimee telehealth service in Wichita, Kansas, in partnership with Stand Together. Aimee offers virtual healthcare, labs, and prescription drugs to patients, regardless of health insurance. The service works with local community centres to transform them into centers of care, providing virtual urgent care, primary care, and medical weight loss with exercise programs to improve the health of residents in Wichita's communities.
• In November 2024, MedAdvisor Solutions, a global leader in pharmacy-driven patient engagement solutions, has introduced new Telehealth functionality within its MedAdvisor App. This feature was ranked as the third most desirable by pharmacists, according to feedback from its extensive network of pharmacy partners. Telehealth access simplifies the patient healthcare journey, allowing consultations with providers and prescription management from anywhere, at any time.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global telehealth market report delivers a detailed analysis with 70 key tables, more than 60 visually impactful figures, and 199 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Component
• 3.2. Snippet by Delivery Mode
• 3.3. Snippet by Application
• 3.4. Snippet by End User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Need for Remote Patient Monitoring
  • 4.1.2. Restraints
    • 4.1.2.1. Lack of Robust Infrastructure and Limited Digital Literacy in Developing Regions
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Component

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 6.1.2. Market Attractiveness Index, By Component
• 6.2. Hardware*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Software
• 6.4. Services

7. By Delivery Mode

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 7.1.2. Market Attractiveness Index, By Delivery Mode
• 7.2. On-Premise*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Cloud-based

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Chronic Disease Management*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Mental Health & Behavioral Disorders
• 8.4. Radiology
• 8.5. Cardiology
• 8.6. Neurology
• 8.7. Dermatology
• 8.8. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Healthcare Providers*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Patients
• 9.4. Payers
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

• 12.1. Teladoc Health, Inc*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio
    • 12.1.2.1. Product Description
    • 12.1.2.2. Product Key Performance Indicators (KPIs)
    • 12.1.2.3. Historic and Forecasted Product Sales
    • 12.1.2.4. Product Sales Volume
  • 12.1.3. Financial Overview
    • 12.1.3.1. Company Revenue's
    • 12.1.3.2. Geographical Revenue Shares
    • 12.1.3.3. Revenue Forecasts
  • 12.1.4. Key Developments
    • 12.1.4.1. Mergers & Acquisitions
    • 12.1.4.2. Key Product Development Activities
    • 12.1.4.3. Regulatory Approvals etc.
  • 12.1.5. SWOT Analysis
• 12.2. American Well Corporation (Amwell)
• 12.3. MDLIVE Inc.
• 12.4. Doctor On Demand, Inc
• 12.5. Philips Healthcare
• 12.6. Medtronic plc
• 12.7. GE Healthcare
• 12.8. Siemens Healthineers AG
• 12.9. Epic Systems Corporation
• 12.10. Doximity
• Similar data will be provided for each market player.

Emerging Market Players

• 12.11. Babylon Health*
  • 12.11.1. Pipeline Products Description
  • 12.11.2. Product Key Performance Indicators (KPIs)
  • 12.11.3. Key Activities
  • 12.11.4. Market Entry Timelines
  • 12.11.5. Product Penetration Rate
  • 12.11.6. Sales Estimation and Projections
• 12.12. K Health
• 12.13. Hims & Hers Health, Inc
• 12.14. MyDoc
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us